EventsMOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Published
This submission belongs to the session 07. TECHLAW.SCI-06: Technol., & Law Sci. Congresses, Bayonne, France-Miami, USA, 2022. of the event MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Published date
11 Dec, 2022
Academic Editor
author-avatarHumbert G. Díaz
Citation
Ahmed Fatimi, Reda El Boukhari, Use of chemical compound searches to study the patentability of rosmarinic acid, in Proceedings of MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed., 1 January–15 January 2023, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-08-13846
Share
Email
Facebook
Twitter
LinkedIn

Use of chemical compound searches to study the patentability of rosmarinic acid

image
image
1. Chemical Science and Engineering Research Team (ERSIC), Department of Chemistry, Polydisciplinary Faculty of Beni Mellal (FPBM), Sultan Moulay Slimane University (USMS), P.O. Box 592 Mghila, Beni Mellal 23000, Morocco
Abstract

Rosmarinic acid is a phenolic compound that occurs naturally in many higher plants, particularly Lamiaceae. The name of this acid is based on the plant's name from which it was first isolated, Rosmarinus officinalis. Since rosmarinic acid has several biological activities, including antioxidant, antibacterial, hepatoprotective, and cardioprotective properties, it has been very useful for pharmaceutical, cosmetic, and food applications. This work, in the form of a patent analysis, presents the state by introducing what has been innovated and patented concerning rosmarinic acid. Furthermore, a detailed analysis of the patentability, using the "chemical compounds search" of the PATENTSCOPE database, has been provided regarding publication years, jurisdictions, and patent classifications.

Keywords
Rosmarinic acid
Rosmarinus officinalis
chemical compounds search
patentability
patent analysis.
Manuscript
Virtual Screening Multitarget-Based Against 3CLpro and TMPRSS2 Reveals New Promising Drugs Against SARS-CoV-2.

IKERDATA S.L. A New Company Focused on AI-Driven Data Analysis Services, Scientific, and Regulatory Consulting for Chemoinformatics and Biomedical Engineering.